Andrew Bell

Andrew Bell has extensive experience in the pharmaceutical industry, holding various roles from Senior Product Manager at Chiesi USA, Inc. to Associate Director of Marketing at Dova Pharmaceuticals. Notably, Bell managed the relaunch of CLEVIPREX and successfully launched the billion-dollar HIV drug GENVOYA while at Gilead Sciences. Prior experience includes positions as Sales Representative III at Daiichi Sankyo, where prescription habits of cardiovascular products were increased, and as Senior Therapeutic Specialist. Andrew Bell holds a Master of Business Administration from Golden Gate University and a Bachelor's degree in Business Management and MIS from Elon University.